首页 | 本学科首页   官方微博 | 高级检索  
     

影响ERCP胆道支架置入术治疗恶性梗阻性黄疸疗效的危险因素
引用本文:段玉灵,范国鑫,李凯,王磊,刘康伟,彭慈军. 影响ERCP胆道支架置入术治疗恶性梗阻性黄疸疗效的危险因素[J]. 中国普通外科杂志, 2022, 31(2): 208-216
作者姓名:段玉灵  范国鑫  李凯  王磊  刘康伟  彭慈军
作者单位:1.遵义医科大学附属医院 肝胆外科,贵州 遵义 563000;2.遵义医科大学 生物化学与分子生物学教研室,贵州 遵义 563000
摘    要:背景与目的:经内镜逆行性胰胆管造影(ERCP)胆道支架置入术是治疗无根治手术机会的恶性梗阻性黄疸(MOJ)患者疗效较好的微创介入治疗方式,但影响其早期减黄效果的危险因素目前暂不明确.因此本研究分析影响其治疗效果的危险因素,为临床干预提供参考.方法:回顾性收集2014年1月-2021年1月遵义医科大学附属医院肝胆外科收治...

关 键 词:黄疸,阻塞性  胰胆管造影术,内窥镜逆行  支架  危险因素
收稿时间:2021-10-08
修稿时间:2022-01-28

Risk factors for bilirubin lowering effect of ERCP-guided biliary stent placement in treatment of malignant obstructive jaundice
DUAN Yuling,FAN Guoxin,LI Kai,WANG Lei,LIU Kangwei,PENG Cijun. Risk factors for bilirubin lowering effect of ERCP-guided biliary stent placement in treatment of malignant obstructive jaundice[J]. Chinese Journal of General Surgery, 2022, 31(2): 208-216
Authors:DUAN Yuling  FAN Guoxin  LI Kai  WANG Lei  LIU Kangwei  PENG Cijun
Affiliation:1.Department of Hepatobiliary Surgery, Affiliated Hospital of Zunyi Medical University, Zunyi, Guizhou 563000; China;2.Department of Biochemistry and Molecular Biology, Zunyi Medical University, Zunyi, Guizhou 563000; China
Abstract:Background and Aims Endoscopic retrograde cholangiopancreatography (ERCP)-guided biliary stent placement is a minimally invasive interventional therapy with demonstrable efficacy for patients with malignant obstructive jaundice (MOJ) who have no chance of radical surgery. However, the risk factors affecting the early bilirubin lowering effect are still unclear yet. Therefore, this study was conducted to analyze the risk factors affecting the therapeutic effect, so as to provide guidance for clinical intervention.Methods The clinical data of MOJ patients with no chance of radical surgery undergoing ERCP-guided biliary stent placement from January 2014 to January 2021 in Department of Hepatobiliary Surgery, Affiliated Hospital of Zunyi Medical University were retrospectively collected. The bilirubin lowering effects on 4-7 d and 1 month after operation were observed. The risk factors affecting the bilirubin lowering effect were determined by univariate analysis and multivariate Logistic regression analysis.Results A total of 171 patients undergoing successful ERCP-guided biliary stent placement were enrolled. Of the 171 patients, the total bilirubin (TBIL) level decreased more than 30% compared with the preoperative value in 100 cases (significant efficacy), and the degree of TBIL decrease did not reach above standard in 61 patients (unsatisfactory efficacy), and the total effective rate was 64.3% (110/171). Among the 63 patients with complete postoperative 1 month follow-up data, the TBIL level returned to normal in 31 cases and did not return to normal in 32 cases, and the total recovery rate was 49.2%. High-grade obstruction (OR=9.223, P<0.01) and preoperative Child-Pugh class C (OR=2.864, P<0.01) were independent risk factors for bilirubin lowering effect on 4-7 d after operation. High-grade obstruction (OR=13.813, P<0.05) and plastic stent implantation (OR=76.981, P<0.01) were independent risk factors for bilirubin lowering effect on 1 month after surgery.Conclusion ERCP-guided biliary stent implantation is an effective way to reduce jaundice in MOJ patients losing the chance of radical surgery. For patients with risk factors affecting bilirubin lowering, the relevant intervention should be undertaken as much as possible and physician-patient communication should be reinforced. As for the stent selection, comprehensive consideration involving many factors is recommended.
Keywords:Jaundice, Obstructive  Cholangiopancreatography, Endoscopic Retrograde  Stents  Risk Factors
点击此处可从《中国普通外科杂志》浏览原始摘要信息
点击此处可从《中国普通外科杂志》下载免费的PDF全文
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号